- Health Canada DPD: INSTILLAGEL (PENDOPHARM DIVISION OF PHARMASCIENCE INC, DIN 02294990) · product monograph (PDF)
Links only. These regulators' terms do not clearly permit reproducing the documents, so no text is shown here. Check the Philippine package insert in the products table.
Component information
No US or EU label exists for this exact combination, so information is shown for each component.
Use: Uses healthcare personnel handwash: helps reduce bacteria that potentially can cause disease skin wound and general skin cleansing US FDA label
Use: Xylocaine (lidocaine HCl) Injections are indicated for production of local or regional anesthesia by infiltration techniques such as percutaneous injection and intravenous regional anesthesia by peripheral nerve block… US FDA label
Note: Fixed-dose combinations may not allow the dose changes advised for each component; check the strength and use the single agents if a component needs adjusting.
Dosing: Altered kidney function
No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.
Kidney dosing for each component (single-agent) is shown under Component information.
Kidney-specific guidance from renalcarematters.com: in preparation.
Dosage forms
Philippines
- Per gram gel for instillation: 20 mg/500 mcg
Registered products in the Philippines
1 product registered with the Food and Drug Administration (FDA) Philippines list Chlorhexidine + Lidocaine as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.
| Package insert | |||||||
|---|---|---|---|---|---|---|---|
CathejellLidocaine hydrochloride + Chlorhexidine dihydrochloride | 20 mg/500 mcg per gram (2% w/w / 0.05% w/w) Gel for InstillationPolypropylene Accordion Syringe with Polypropylene Applicator Cone by 12.5 g in blister pouches (Box of 25's) | Rx | Pharmazeutische Fabrik Montavit GesmbHAustria | Metro Drug, Inc.Importer: New Marketlink Pharmaceutical Corporation | DR-XY45604 | Oct 4, 2036 |
Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.
Formulary and pricing (Philippines)
Check availability
Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.
References
- Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph
This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.
Last updated: .